NeuroPace, Inc.
NPCE
$14.09
-$0.03-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.80% | 16.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.80% | 16.30% | |||
| Cost of Revenue | -2.85% | 14.81% | |||
| Gross Profit | -2.79% | 16.74% | |||
| SG&A Expenses | -10.90% | -5.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.34% | -1.29% | |||
| Operating Income | 32.04% | 61.90% | |||
| Income Before Tax | 21.94% | 59.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.94% | 59.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.94% | 59.59% | |||
| EBIT | 32.04% | 61.90% | |||
| EBITDA | 33.74% | 62.39% | |||
| EPS Basic | 22.56% | 59.92% | |||
| Normalized Basic EPS | 21.24% | 59.94% | |||
| EPS Diluted | 22.56% | 59.92% | |||
| Normalized Diluted EPS | 21.24% | 59.94% | |||
| Average Basic Shares Outstanding | 0.76% | 0.83% | |||
| Average Diluted Shares Outstanding | 0.76% | 0.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||